We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 86

Sham-wow! antitrust liability may attach to sham administrative petitions
  • McDermott Will & Emery
  • USA
  • October 1 2014

Addressing whether the “sham” exception to Noerr-Pennington immunity is limited to sham litigation in courts, the U.S. Court of Appeals for the


Focus on regulatory law - October 2014
  • McDermott Will & Emery
  • France
  • October 3 2014

The applicant claimed that the provisions of I, Article L. 430-8 of the French Commercial Code, which allows the Competition Authority to fine


Court certifies class in hospital merger antitrust lawsuit
  • McDermott Will & Emery
  • USA
  • December 19 2013

On December 10, 2013, Judge Edmond Chang of the Northern District of Illinois certified a class of plaintiffs who filed a proposed class action


North Carolina Dental Board urges reversal of FTC’s “radical” stance on state action immunity
  • McDermott Will & Emery
  • USA
  • September 5 2014

North Carolina's State Board of Dental Examiners has urged the U.S. Supreme Court to reject the Federal Trade Commission's (FTC's) "radical


Federal judge puts narcolepsy drug horizontal conspiracy claims to bed
  • McDermott Will & Emery
  • USA
  • June 27 2014

On Monday, June 23, 2014, a Federal Judge in the Eastern District of Pennsylvania granted summary judgment for five pharmaceutical companies on


Second Circuit to hear expedited appeal in “product hopping” suit
  • McDermott Will & Emery
  • USA
  • January 9 2015

On January 6, 2015, the Second Circuit granted defendants’ motion for an expedited appeal but denied their motion for a stay in New York v


Supreme Court limits availability of state action immunity from federal antitrust liability
  • McDermott Will & Emery
  • USA
  • February 20 2013

The Supreme Court decision in FTC v. Phoebe Putney Health System, Inc., makes clear that state action immunity from federal antitrust laws is


Contractual duty to deal does not equal antitrust duty to deal
  • McDermott Will & Emery
  • USA
  • July 30 2014

Addressing for the first time whether a patent holder under a contractual duty to deal is also subject to an antitrust duty to deal, the U. S. Court


FTC takes a broad, "generic" approach to Actavis in Amicus brief
  • McDermott Will & Emery
  • USA
  • August 22 2013

The Federal Trade Commission's (FTC) battle against "reverse-payment" settlements continues. In an amicus brief recently submitted in the case of In


The case of ophthalmic drugs in Italy and France: a lesson to learn - parallel antitrust investigations and cooperation between national competition authorities
  • McDermott Will & Emery
  • European Union, France, Italy
  • May 7 2014

The recent investigations into two pharmaceutical companies active in the ophthalmic drugs market in Italy and France serve as a reminder of the